Skip to main contentSkip to navigation
Sirius Investors
Guardant Health, Inc.

Guardant Health, Inc.

GH
NASDAQHealthcare

Guardant Health, Inc. (GH) Financial Metrics

This dashboard provides comprehensive financial metrics and analysis to help evaluate Guardant Health, Inc.'s investment potential. View key valuation ratios, profitability metrics, growth indicators, and historical trends to make informed investment decisions.

Financial Metrics Score

Valuation Metrics

Sector benchmarks: Industrials

2025
P/E Ratio
-30.77
Burn Risk
P/B Ratio
-128.95
Equity Deficit
Earnings Yield
-3.25%
Yield Gap

Profitability Health

2025
Return on Equity
419.18%
Strong
WeakModerateStrong
Operating Margin
-44.43%
Weak
WeakModerateStrong
Net Profit Margin
-42.39%
Weak
WeakModerateStrong

Growth Indicators

2025
Revenue Growth
32.88%
Strong
WeakModerateStrong
Net Income Growth
4.61%
Weak
WeakModerateStrong
EPS Growth
6.74%
Weak
WeakModerateStrong

Efficiency & Liquidity

2025
Current Ratio
4.84
Strong
WeakModerateStrong
Quick Ratio
4.56
Strong
WeakModerateStrong
Asset Turnover
0.49x
Weak
WeakModerateStrong
Inventory Turnover
4.06x
Moderate
WeakModerateStrong

Cash Flow & Resilience

Core fortress metrics for cash-rich balance sheets in high-inflation / tech-volatility regimes

2025
Free Cash Flow Yield
-1.82%
Weak
WeakModerateStrong
EV / Free Cash Flow
-60.66x
Strong
WeakModerateStrong
Net Debt / EBITDA
-3.56x
Strong
WeakModerateStrong
Interest Burden (EBT / EBIT)
0.957
Strong
WeakModerateStrong
Return on Invested Capital
-25.02%
Weak
WeakModerateStrong
Cash Conversion Cycle
84.11 days
Weak
WeakModerateStrong

Fortress screener guardrails

1/4 passing
  • FCF Yield > 3%
  • Net Debt / EBITDA < 1.5x
  • ROIC > 20%
  • Cash Conversion Cycle < 0 days

Financial Statements

Want to see the complete financial picture? View detailed financial statements including income statements, balance sheets, and cash flow statements for GH.

View Financial Statements